Global Tissue Diagnostics Market Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030


Tissue Diagnostics Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030

SKU: FPG0708 Category: Tag:


Tissue Diagnostics Market

Market Overview
Tissue diagnostics is analyzing and evaluating particular tissue samples in order to understand the biological background of illnesses. They are used to detect specific medical problems including as cancer and inflammatory illnesses, as well as indicate the precise kind and degree of malignancy, which aids in the identification of probable causes and treatment choices. Tissue diagnostics are very accurate, low-cost, and may be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling. The disease insights and factors that influence patient outcomes are captured by tissue diagnostics. Tissues, in general, provide for individualized diagnosis and therapy. The majority of samples are made up of tissue fragments collected through various procedures. Small biopsies and huge specimens extracted during surgery are examples. Other important factors driving the market’s growth are rising healthcare expenditures and technical developments in tissue diagnostics.

Tissue Diagnostics Market: Key Players
Abbott Laboratories

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Agilent Technologies Inc.
BioGenex Laboratories
Cancer Genetics Inc.
Danaher Corporation
F. Hoffmann-La Roche Ltd
Genomic Health Inc.
Merck KGaA
Thermo Fisher Scientific.
Bio Rad

Growth Factor
Increased cancer patients
The number of persons diagnosed with cancer has increased as a result of changing lifestyles, increased cigarette and alcohol intake, and rising incidence of lifestyle problems. The need for tissue diagnostics in the treatment of breast cancer, prostate cancer, and other cancers is propelling the market during the forecast period, owing to a growth in the population and an increase in chronic illnesses throughout the world.

By Product
Reagents & Consumables
By Technology
In-Situ Hybridization
Digital Pathology & Workflow Management
By Disease
Breast Cancer
Prostate Cancer
Gastric Cancer
Other Cancers
By End-User
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Tissue Diagnostics Market Dynamics
Tissue Diagnostics Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

Recent News Related to Market
In 2019, Roche and GE Healthcare have agreed to collaborate on the development of an integrated digital diagnostics platform aimed at improving cancer and critical care therapy.

In 2019, Hologic received CE permission for ThinPrep Genesis Processor.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Tissue Diagnostics Market growth?
Which segment accounted for the largest Tissue Diagnostics Market share?
Who are the key players in the Tissue Diagnostics Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Additional information


Geography Covered

Date Published




Table of Contents

1. Executive Summary
2. Global Tissue Diagnostics Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Tissue Diagnostics Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Tissue Diagnostics Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Tissue Diagnostics Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Instruments, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Reagents and Consumables, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Technology: Market Share (2020-2030F)
12.3.1. Immunohistochemistry , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. In-Situ Hybridization, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Digital Pathology & Workflow Management, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Diseases: Market Share (2020-2030F)
12.4.1. Breast cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Prostate cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Gastric cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Other cancers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End-User: Market Share (2020-2030F)
12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Contract Research Organizations, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Research Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Agilent Technologies Inc.
13.3. BioGenex Laboratories
13.4. Cancer Genetics Inc.
13.5. Danaher Corporation
13.6. Hoffmann-La Roche Ltd
13.7. Genomic Health Inc.
13.8. Merck KGaA
13.9. Thermo Fisher Scientific.
13.10. Bio Rad
13.11. Biomeriux
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.